A detailed history of Breed'S Hill Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Breed'S Hill Capital LLC holds 457 shares of LLY stock, worth $357,908. This represents 0.33% of its overall portfolio holdings.

Number of Shares
457
Previous 547 16.45%
Holding current value
$357,908
Previous $495 Million 18.25%
% of portfolio
0.33%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$772.14 - $960.02 $69,492 - $86,401
-90 Reduced 16.45%
457 $405 Million
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $4,349 - $5,454
-6 Reduced 1.08%
547 $495 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $19,542 - $26,145
-33 Reduced 5.63%
553 $430 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $307,761 - $362,810
586 New
586 $342 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Breed'S Hill Capital LLC Portfolio

Follow Breed'S Hill Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breed'S Hill Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Breed'S Hill Capital LLC with notifications on news.